Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 7, 2019
Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation
Sam Tozay, William A Fischer, David A Wohl, et al.
The Lancet. Infectious Diseases
|
November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Anthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
Open Forum Infectious Diseases
|
March 26, 2026
Serologic Evidence of Hemorrhagic Fever Virus Spillover in Rural Liberia
Adam M Schafer, Emmanuel Kerkula, Chanhwa Lee, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Science Translational Medicine
|
December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A Fischer, Joseph J Eron, Wayne Holman, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
The Lancet. Infectious Diseases
|
January 10, 2026
Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia
David A Wohl, Carwolo Pewu, Chanhwa Lee, et al.
The Lancet. HIV
|
July 15, 2024
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial
David A Wohl, Christoph D Spinner, Jason Flamm, et al.
Nature Medicine
|
August 28, 2024
Health and economic impacts of Lassa vaccination campaigns in West Africa
David R M Smith, Joanne Turner, Patrick Fahr, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 7, 2019
Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation
Sam Tozay, William A Fischer, David A Wohl, et al.
The Lancet. Infectious Diseases
|
November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Anthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
Open Forum Infectious Diseases
|
March 26, 2026
Serologic Evidence of Hemorrhagic Fever Virus Spillover in Rural Liberia
Adam M Schafer, Emmanuel Kerkula, Chanhwa Lee, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Science Translational Medicine
|
December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A Fischer, Joseph J Eron, Wayne Holman, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
The Lancet. Infectious Diseases
|
January 10, 2026
Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia
David A Wohl, Carwolo Pewu, Chanhwa Lee, et al.
The Lancet. HIV
|
July 15, 2024
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial
David A Wohl, Christoph D Spinner, Jason Flamm, et al.
Nature Medicine
|
August 28, 2024
Health and economic impacts of Lassa vaccination campaigns in West Africa
David R M Smith, Joanne Turner, Patrick Fahr, et al.
Page
of 19